Candidemia Market Analysis

Candidemia is the most common fungal bloodstream infection, and possibly the fourth most common all-type bloodstream infection seen in the intensive care unit setting. The incidence of Candida bloodstream infection is bimodal, with the elderly and very young having the highest risk of any population for suffering from this disease.

Common symptoms of candidemia include fever and chills that do not improve with antibiotics. The infection can also cause septic shock and therefore may include symptoms such as low blood pressure, fast heart rate, and rapid breathing.

As per the study titled “National Burden of Candidemia, United States, 2017” by Tsay et al. (2018), suggests that an estimated 23,000 candidemia cases occurred in the United States in 2017. Overall estimated incidence was calculated to be 7.0 per 100,000 persons, with elevated rates in adults ≥65 years (20.3 per 100,000), males (8.0 per 100,000).

For more details on Candidemia Market Insights, Epidemiology, and Pipeline Analysis, visit: https://www.delveinsight.com/report-store/candidemia-market